Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

Sigma (ASX:SIG) share price soars 30% on ACCC-approved Chemist Warehouse merger

The Sigma Healthcare Ltd (ASX:SIG) share price has jumped 31% after the merger with Chemist Warehouse was approved. 

The Sigma Healthcare Ltd (ASX: SIG) share price has jumped 31% after the merger with Chemist Warehouse was approved.

Sigma-Chemist Warehouse merger approved

The ACCC announced that it does not oppose the merger between Sigma and Chemist Warehouse, on condition it follows through with a court-enforceable undertaking.

Why approve it? The Australian Competition & Consumer Commission made a few points.

The competition regulator said that it believes, with the undertaking, the proposed merger is “unlikely to substantially lessen competition”. It believes there will continue to be effective competition at all levels of the pharmacy supply chain, “capable of constraining a combined Sigma Chemist Warehouse”.

The ACCC came to this conclusion with the thought that other pharmacies and non-pharmacy retailers will “continue to compete to the same extent they compete now”.

Consumers will continue to have a choice between smaller format stores offering personalised services to consumers, and the Chemist Warehouse offering focused on larger format discount stores and front-of-store offerings.

The ACCC points to competing wholesalers such as EBOS Group Ltd (ASX: EBO) and Wesfarmers Ltd‘s (ASX: WES) Australian Pharmaceutical Industries, which can continue to distribute PBS medicines and supply retail pharmacy customers.

Retail pharmacies “do not face significant barriers to switching”, according to the ACCC.

Undertakings

Sigma will not enforce contractual restrictions on exit by retail pharmacies and ensures payments under contracts do not make it costly for a pharmacy to switch.

The enforceable undertaking also requires Sigma to safeguard and delete the data of those pharmacies that choose to switch. Sigma Chemist Warehouse must continue as a pharmaceutical wholesaler under the Commonwealth Government’s Community Service Obligation (CSO) arrangements for five years.

Management commentary

The Sigma CEO and Managing Director Vikesh Ramsunder said:

The ACCC decision marks a critical milestone for the proposed transaction and provides us with the conviction to progress with the next steps in the process.

The proposed transaction has the potential to create a leading ASX listed healthcare company through the combination of the complementary strengths of Sigma’s state-of-the-art pharmaceutical distribution infrastructure with Chemist Warehouse Group’s retailing know-how. We believe the proposed merger will create a stronger business and accelerate our long-term growth ambitions, for the benefit of our stakeholders.

Final thoughts on the Sigma share price

Sigma said it’s well-advanced in preparing the documentation shareholders require to vote on the proposed transaction, which must be reviewed by regulators before it can be sent to shareholders.

The regulatory review is expected to occur this calendar year. After the review is finished, Sigma will tell investors about the transaction timing.

It will be interesting to have the Chemist Warehouse business on the ASX, which has compelling growth plans.

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

At the time of publishing, Jaz does not have a financial or commercial interest in any of the companies mentioned.
Skip to content